CN1381252A - Chines medicine for treating silicosis - Google Patents

Chines medicine for treating silicosis Download PDF

Info

Publication number
CN1381252A
CN1381252A CN02109582A CN02109582A CN1381252A CN 1381252 A CN1381252 A CN 1381252A CN 02109582 A CN02109582 A CN 02109582A CN 02109582 A CN02109582 A CN 02109582A CN 1381252 A CN1381252 A CN 1381252A
Authority
CN
China
Prior art keywords
radix
silicosis
borax
bletillae
rhizoma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN02109582A
Other languages
Chinese (zh)
Other versions
CN1201758C (en
Inventor
史艳梅
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNB021095825A priority Critical patent/CN1201758C/en
Publication of CN1381252A publication Critical patent/CN1381252A/en
Application granted granted Critical
Publication of CN1201758C publication Critical patent/CN1201758C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A Chinese medicine for treating silicosis is prepared from 18 Chinese medicinal materials including lysimachia, chicken's gizzard-skin, borax, white peony root, etc.. This invention adopts scientifice selection of medicines and proper compatibility. Its advantages are high curative effect, and high cure rate.

Description

The Chinese medicine of treatment anthraco-silicosis
(1) technical field
The present invention relates to a kind of Chinese medicine for the treatment of pneumonopathy, particularly relate to a kind of Chinese medicine of the anthraco-silicosis of suffering from because of under dust atmosphere, working for a long time.
(2) background technology
Silicon also claims silicon, is a kind of chemical element." anthraco-silicosis " contains free silicon dioxide in a large number when being human body respiration dust enters the caused occupation disease of pulmonary.This disease is everlasting and is taken place in the work posts such as the higher mining of silica dust concentration in the air, rock drilling, manufacture of cement, can make the people cough, symptom such as uncomfortable in chest, out of breath occur, and easily send out pulmonary tuberculosis.
Anthraco-silicosis is to harden in pulmonary because of sucking a large amount of dust, impels pulmonary function progressively depleted, last causing death.According to the degree that hardens of pulmonary, this disease was divided into for three phases.Along with the state of an illness increases the weight of, the patient understands symptoms such as concurrent emphysema, heart failure.
Anthraco-silicosis is the most ancient in the world, the most extensive generation, and do not have the disease of specific treatment, so, must be paid much attention to, actively take safeguard procedures.Tellurian rock comprises granite, sandstone, quartzite etc., all contains the above free silicon dioxide of 60%-90%.
China pays much attention to workers ' health, and multiple measure has been taked in the control of anthraco-silicosis, has also obtained certain effect.Connect the dust in dirt work position as national regulation, must not surpass 2 milligrams in every cubic metres of air, require to prevent and treat energetically dust hazard, through continuous effort, the dust qualification rate of many factories and miness has been brought up to more than 80% gradually.So anthraco-silicosis extends to more than ten years to two just morbidity more than 10 years, such achievement is hard-earned.But, later on because the influence of turmoils such as the Culture Revolution, achievement is not consolidated, and has added since the reform and opening-up, and large quantities of township enterprises rises, overseas-funded enterprise enters, the dust hazard of a lot of factories and miness has been on the rise again, and according to the Ministry of Public Health statistics in 1999 years, the existing pneumosilicosis patient of China has reached 550,000 people, prevent silicious dust harm, remain the cardinal task of work hygiene.
(3) summary of the invention
The technical problem to be solved in the present invention provides a kind of Chinese medicine that can effectively treat anthraco-silicosis.
The technical scheme that adopts is:
The Chinese medicine of treatment anthraco-silicosis, be by Herba Lysimachiae, Endothelium Corneum Gigeriae Galli, borax, Fructus Schisandrae Chinensis, Radix Aconiti Lateralis Preparata, the Radix Paeoniae Alba, the Radix Astragali, Cortex Acanthopancis, Herba Asari, Ramulus Cinnamomi, Radix Glycyrrhizae, Fructus Gleditsia, Radix Platycodonis, the Pseudobulbus Bletillae (Rhizoma Bletillae), Bulbus Fritillariae Uninbracteatae, Flos Farfarae, Rhizoma Zingiberis, Folium Eriobotryae, its compatibility is: Herba Lysimachiae 5-10g, Endothelium Corneum Gigeriae Galli 5-8g, borax 15-30g, Fructus Schisandrae Chinensis 5-15g, Radix Aconiti Lateralis Preparata 8-15g, Radix Paeoniae Alba 8-12g, Radix Astragali 10-15g, Cortex Acanthopancis 10-12g, Herba Asari 3-5g, Ramulus Cinnamomi 5-10g, Radix Glycyrrhizae 3-5g, Fructus Gleditsia 15-20g, Radix Platycodonis 15-20g, Pseudobulbus Bletillae (Rhizoma Bletillae) 15-20g, Bulbus Fritillariae Uninbracteatae 5-10g, Flos Farfarae 15-20g, Rhizoma Zingiberis 5-8g, Folium Eriobotryae 5-10g.
The system treatment method of the Chinese medicine of treatment anthraco-silicosis, be to get Herba Lysimachiae 5-10g, Endothelium Corneum Gigeriae Galli 5-8g, borax 15-30g, Fructus Schisandrae Chinensis 5-15g, Radix Aconiti Lateralis Preparata 8-15g, Radix Paeoniae Alba 8-12g, Radix Astragali 10-15g, Cortex Acanthopancis 10-12g, Herba Asari 3-5g, Ramulus Cinnamomi 5-10g, Radix Glycyrrhizae 3-5g, Fructus Gleditsia 15-20g, Radix Platycodonis 15-20g, Pseudobulbus Bletillae (Rhizoma Bletillae) 15-20g, Bulbus Fritillariae Uninbracteatae 5-10g, Flos Farfarae 15-20g, Rhizoma Zingiberis 5-8g, Folium Eriobotryae 5-10g by compatibility, pulverize mix homogeneously, incapsulate and be finished product.
The side separates:
Herba Lysimachiae: go into liver, gallbladder, kidney, urinary bladder channel, heat clearing away, diuretic, Tonglin Paishi.
Endothelium Corneum Gigeriae Galli: go into spleen, stomach, small intestinal, urinary bladder channel, strengthening the spleen and stomach, eliminating indigested food arresting enursis, the inducing decomposition of calculi.
Borax: toxicity is less, heat-clearing and toxic substances removing, cool in nature, sweet in the mouth, little salty.
Fructus Schisandrae Chinensis: astringing lung-QI and relieving cough.
Radix Aconiti Lateralis Preparata: tonifying YANG kidney tonifying, warm aproll gas.
The Radix Paeoniae Alba: relieving spasm to stop pain.
The Radix Astragali: supplementing QI to induce diuresis.
In sum, the Chinese medicine of treatment anthraco-silicosis of the present invention as can be known, the science of getting it filled, compatibility is proper, has the effect of treatment anthraco-silicosis.
Using method:
Every day three times, each 8, five months is a course of treatment, and can obtain excellent curative general 4 courses of treatment.
(4) specific implementation method
The Chinese medicine of treatment anthraco-silicosis, be by Herba Lysimachiae 9g, Endothelium Corneum Gigeriae Galli 7g, borax 30g, Fructus Schisandrae Chinensis 10g, Radix Aconiti Lateralis Preparata 10g, Radix Paeoniae Alba 9g, Radix Astragali 12g, Cortex Acanthopancis 10g, Herba Asari 4g, Ramulus Cinnamomi 9g, Radix Glycyrrhizae 4g, Fructus Gleditsia 18g, Radix Platycodonis 18g, Pseudobulbus Bletillae (Rhizoma Bletillae) 18g, Bulbus Fritillariae Uninbracteatae 9g, Flos Farfarae 18g, Rhizoma Zingiberis 3g, Folium Eriobotryae 9g pulverize, being mixed is mixed with, can incapsulate, make wafer.
With the Chinese medicine of treatment anthraco-silicosis of the present invention, 38 examples are suffered from the molybdenum ore workman and the 9 routine cement plant work of suffering from anthraco-silicosises of anthraco-silicosis and treated, obey every day three times, 8 of each clothes, five months is a course of treatment, total effective rate is 98%, cure rate 90% is welcome by the patient very.
Model case:
Cao Zhongyu, the man, 52 years old, suffered from anthraco-silicosis 15 years, through curing in many ways, effect is bad, and the patient is very painful, begins to eat the Chinese medicine of treatment anthraco-silicosis May 2 calendar year 2001, every day three times, each 8, in February, 2002, fully recovers through the fluoroscopic examination anthraco-silicosis.

Claims (2)

1, the Chinese medicine of treatment anthraco-silicosis, it is characterized in that by Herba Lysimachiae, Endothelium Corneum Gigeriae Galli, borax, Fructus Schisandrae Chinensis, Radix Aconiti Lateralis Preparata, the Radix Paeoniae Alba, the Radix Astragali, Cortex Acanthopancis, Herba Asari, Ramulus Cinnamomi, Radix Glycyrrhizae, Fructus Gleditsia, Radix Platycodonis, the Pseudobulbus Bletillae (Rhizoma Bletillae), Bulbus Fritillariae Uninbracteatae, Flos Farfarae, Rhizoma Zingiberis, Folium Eriobotryae is formulated, and its compatibility is: Herba Lysimachiae 5-10g, Endothelium Corneum Gigeriae Galli 5-8g, borax 15-30g, Fructus Schisandrae Chinensis 5-15g, Radix Aconiti Lateralis Preparata 8-15g, Radix Paeoniae Alba 8-12g, Radix Astragali 10-15g, Cortex Acanthopancis 10-12g, Herba Asari 3-5g, Ramulus Cinnamomi 5-10g, Radix Glycyrrhizae 3-5g, Fructus Gleditsia 15-20g, Radix Platycodonis 15-20g, Pseudobulbus Bletillae (Rhizoma Bletillae) 15-20g, Bulbus Fritillariae Uninbracteatae 5-10g, Flos Farfarae 15-20g, Rhizoma Zingiberis 5-8g, Folium Eriobotryae 5-10g.
2, the Chinese medicine of treatment anthraco-silicosis according to claim 1, it is characterized in that by compatibility Herba Lysimachiae, Endothelium Corneum Gigeriae Galli, borax, Fructus Schisandrae Chinensis, Radix Aconiti Lateralis Preparata, the Radix Paeoniae Alba, the Radix Astragali, Cortex Acanthopancis, Herba Asari, Ramulus Cinnamomi, Radix Glycyrrhizae, Fructus Gleditsia, Radix Platycodonis, the Pseudobulbus Bletillae (Rhizoma Bletillae), Bulbus Fritillariae Uninbracteatae, Flos Farfarae, Rhizoma Zingiberis, Folium Eriobotryae is pulverized, being mixed is mixed with medicament, and its compatibility is Herba Lysimachiae 9g, Endothelium Corneum Gigeriae Galli 7g, borax 30g, Fructus Schisandrae Chinensis 10g, Radix Aconiti Lateralis Preparata 10g, Radix Paeoniae Alba 9g, Radix Astragali 12g, Cortex Acanthopancis 10g, Herba Asari 4g, Ramulus Cinnamomi 9g, Radix Glycyrrhizae 4g, Fructus Gleditsia 18g, Radix Platycodonis 18g, Pseudobulbus Bletillae (Rhizoma Bletillae) 18g, Bulbus Fritillariae Uninbracteatae 9g, Flos Farfarae 18g, Rhizoma Zingiberis 3g, Folium Eriobotryae 9g.
CNB021095825A 2002-04-29 2002-04-29 Chines medicine for treating silicosis Expired - Fee Related CN1201758C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB021095825A CN1201758C (en) 2002-04-29 2002-04-29 Chines medicine for treating silicosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB021095825A CN1201758C (en) 2002-04-29 2002-04-29 Chines medicine for treating silicosis

Publications (2)

Publication Number Publication Date
CN1381252A true CN1381252A (en) 2002-11-27
CN1201758C CN1201758C (en) 2005-05-18

Family

ID=4740724

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB021095825A Expired - Fee Related CN1201758C (en) 2002-04-29 2002-04-29 Chines medicine for treating silicosis

Country Status (1)

Country Link
CN (1) CN1201758C (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102058699A (en) * 2010-12-29 2011-05-18 许海涛 Medicine for treating pneumoconiosis
CN102824568A (en) * 2011-06-19 2012-12-19 孙斌 Traditional Chinese medicine for treating silicosis
CN102872190A (en) * 2012-09-10 2013-01-16 顾康春 Chinese traditional medicine for treating silicosis
CN103071047A (en) * 2013-02-05 2013-05-01 许海涛 Decoction for treating silicosis and preparation method thereof
CN103071120A (en) * 2013-01-31 2013-05-01 张玉康 Medicine for treating silicosis
CN103461617A (en) * 2013-10-09 2013-12-25 北京绿源求证科技发展有限责任公司 Food health tea electuary for treating silicosis

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102058699A (en) * 2010-12-29 2011-05-18 许海涛 Medicine for treating pneumoconiosis
CN102058699B (en) * 2010-12-29 2012-05-09 许海涛 Medicine for treating pneumoconiosis
CN102824568A (en) * 2011-06-19 2012-12-19 孙斌 Traditional Chinese medicine for treating silicosis
CN102824568B (en) * 2011-06-19 2014-11-05 师厚刚 Traditional Chinese medicine for treating silicosis
CN102872190A (en) * 2012-09-10 2013-01-16 顾康春 Chinese traditional medicine for treating silicosis
CN102872190B (en) * 2012-09-10 2014-08-20 顾康春 Chinese traditional medicine for treating silicosis
CN103071120A (en) * 2013-01-31 2013-05-01 张玉康 Medicine for treating silicosis
CN103071120B (en) * 2013-01-31 2014-04-30 张玉康 Medicine for treating silicosis
CN103071047A (en) * 2013-02-05 2013-05-01 许海涛 Decoction for treating silicosis and preparation method thereof
CN103461617A (en) * 2013-10-09 2013-12-25 北京绿源求证科技发展有限责任公司 Food health tea electuary for treating silicosis

Also Published As

Publication number Publication date
CN1201758C (en) 2005-05-18

Similar Documents

Publication Publication Date Title
CN1709422A (en) Novel use of Chinese patent medicine formulation with bone-promoting formation for preventing and treating osteoporosis
CN101780167A (en) Chinese medicine compound for preventing and curing lung diseases and clearing human body toxin and preparation method thereof
CN1201758C (en) Chines medicine for treating silicosis
CN1055837C (en) Preparation of brain-care pill
CN1166384C (en) Medicine for relieving cough and asthma
CN1439407A (en) Medicine composition for treatment of cough and asthma and preparation thereof
CN101062259A (en) Lily bolus for clearing lung heat
CN102657706A (en) Infantile anti-cold umbilical therapeutic ointment
CN1365819A (en) Medicine for treating apoplexy
CN1879749A (en) Medicinal heath wine
CN1067571C (en) Chinese medicine capsule for treating lumbar and cervical protrusion
CN1069053C (en) Oral medicine for curing phlegm-heat cough
CN1895629A (en) Chinese-medicinal composition for treating gastropathy
CN1181880C (en) Compound macrostem onion preparation for curing chronic obstructive lung disease and its preparing method
CN101143199A (en) Traditional Chinese medicine for treating chronic bronchitis
CN1059098C (en) Medicine for curing tooth-ache and its preparation
CN1364608A (en) Powder for curing gout
CN1261130C (en) Medicine for dispelling tinea
CN1172699C (en) Chinese medicine for treating syringomyelia
CN109432309A (en) Chinese medicine composition, exterior-applied medical wine and its preparation method and application
Zhang et al. Treating COVID-19 by traditional Chinese medicine: a charming strategy?
CN103550504A (en) Traditional Chinese medicine composition for treating chronic sinusitis
CN1386516A (en) Chinese-medicinal capsule for treating cough asthma
CN1651055A (en) Natural life beneficial Chinese medicine
CN1263493C (en) Medicine for treating chronic bronchitis and asthma

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee